ArticleACS applied materials & interfaces2026
Engineering Liposomes and Polymer Conjugates: A Platform for Mechanistic Complement Activation Studies and Controlled Release Applications.
Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Due to their ability to encapsulate both hydrophilic and hydrophobic molecules and to allow for their controlled release, liposomes have evolved into a promising and frequently used tool in medicine, biotechnology, and bioanalysis. In this work, we designed liposome surfaces and polymer conjugates to reliably and in a controlled fashion activate the complement system and monitor its function. Specifically, the polymer conjugates were designed on protein, polysaccharide, or synthetic polymer backbones, respectively, enabling flexible coupling chemistry and size tuning. They were optimized as trigger entities for efficient stimulation of complement responses through specific surface interactions with the liposome membrane and complement proteins simultaneously. Additionally, the liposome surface chemistry was optimized to ensure the specificity of the binding and complement stimulation. Studies with human serum confirmed the applicability of the new assay principle providing in-depth understanding of complement action. Specifically, increasing the density of trigger moieties enhanced the complement activation efficiency. Complement lysis strongly relies on the physiological geometry of trigger and recognition sites and correlates with cross-linking of liposomes. Since the liposomes demonstrated high long-term stability and the trigger entities offered a range of polymer backbones, this new principle is a platform technology that will be applicable for a broad spectrum of assays, including immunoassays, in-depth investigations of complement activation and regulation, and targeted release of liposome encapsulants for drug delivery systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.